Megan Louise Kuzmich, NP
Nurse Practitioner · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 18 years
- Graduated 2008
Offices
2 locations · Sutter Valley Medical Foundation · 2,473 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Megan Louise Kuzmich’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A18955 · Cancelled
Licence status: Cancelled · since 1959 · Oregon Health Sciences University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$20,661
Pharmacies billed $20,661 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
36 generic and fewer than 11 brand-name prescriptions · $20,661 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 40 | 14 | None | None | $20,661 |
| 2023 | 57 | 18 | None | None | $12,314 |
| 2022 | 71 | 32 | None | 15% | $61,290 |
| 2021 | 439 | 136 | 20% (86) | 19% | $676,647 |
| 2020 | 736 | 196 | 19% (136) | 13% | $249,305 |
| 2019 | 731 | 155 | 11% (78) | None | $38,765 |
| 2018 | 84 | 21 | None | 17% | $17,366 |
| 2017 | 53 | 17 | None | None | $2,493 |
| 2016 | 27 | None | None | None | $33,279 |
| 2015 | 46 | 15 | None | 26% | $6,542 |
| 2014 | 55 | 20 | None | 25% | $7,074 |
| 2013 | 85 | 25 | None | None | $7,233 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 12 drugs
| Calquence | 16 | $230,269 | $14,392 |
| Jakafi | 13 | $210,890 | $16,222 |
| Hydrocodone-Acetaminophen | 34 | $1,065 | $31 |
| Ondansetron | 16 | $550 | $34 |
| Anastrozole | 16 | $513 | $32 |
| Gabapentin | 19 | $382 | $20 |
| Ondansetron Odt | 13 | $354 | $27 |
| Hydromorphone | 11 | $346 | $31 |
| Dexamethasone | 12 | $248 | $21 |
| Prochlorperazine Maleate | 14 | $234 | $17 |
| Olanzapine | 11 | $179 | $16 |
| Acyclovir | 17 | $173 | $10 |
2020: 20 drugs
| Hydrocodone-Acetaminophen | 50 | $1,375 | $28 |
| Morphine Sulfate Er | 19 | $625 | $33 |
| Dexamethasone | 32 | $599 | $19 |
| Oxycodone-Acetaminophen | 16 | $583 | $36 |
| Potassium Chloride | 18 | $496 | $28 |
| Gabapentin | 28 | $396 | $14 |
| Ondansetron Odt | 13 | $371 | $29 |
| Oxycodone | 15 | $348 | $23 |
| Levothyroxine | 18 | $347 | $19 |
| Ondansetron | 11 | $307 | $28 |
| Hydromorphone | 11 | $294 | $27 |
| Atorvastatin | 13 | $265 | $20 |
| Olanzapine | 19 | $222 | $12 |
| Famotidine | 16 | $168 | $11 |
| Prednisone | 15 | $132 | $9 |
| Prochlorperazine Maleate | 11 | $122 | $11 |
| Omeprazole | 12 | $96 | $8 |
| Simvastatin | 20 | $79 | $4 |
| Lorazepam | 11 | $57 | $5 |
| Meloxicam | 21 | $45 | $2 |
2019: 13 drugs
| Rosuvastatin | 31 | $2,157 | $70 |
| Hydrocodone-Acetaminophen | 52 | $854 | $16 |
| Gabapentin | 19 | $604 | $32 |
| Atorvastatin | 16 | $495 | $31 |
| Levothyroxine | 15 | $348 | $23 |
| Nitrofurantoin Mono-Macro | 11 | $230 | $21 |
| Meloxicam | 46 | $147 | $3 |
| Lisinopril | 21 | $140 | $7 |
| Sertraline | 11 | $135 | $12 |
| Amoxicillin-Clavulanate Potass | 11 | $116 | $11 |
| Simvastatin | 19 | $101 | $5 |
| Prednisone | 14 | $72 | $5 |
| Hydrochlorothiazide | 12 | $38 | $3 |
2018: 1 drug
| Famotidine | 11 | $100 | $9 |
2015: 1 drug
| Estradiol | 13 | $89 | $7 |
2014: 1 drug
| Estradiol | 18 | $90 | $5 |
2013: 1 drug
| Estradiol | 13 | $508 | $39 |
Money from drug and device companies
$24 in 2022
| 2022 | 1 | 1 | None | $24 |
| 2021 | 31 | 102 | None | $1,586 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Ultomiris | $24 | 1 payment
|
See the published payment
| Alexion Pharmaceuticals | Meals · 2022-07-11 | Ultomiris | $24 |
See earlier years (2021)
2021: $1,586
| Amgen | Lumakras | $205 | 10 payments
|
| Seagen | Padcev | $121 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $114 | 5 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $100 | 4 payments
|
| Astellas Pharma US | Padcev | $93 | 2 payments
|
| Novartis Pharmaceuticals | Adakveo | $77 | 4 payments
|
| TerSera Therapeutics | Zoladex | $76 | 4 payments
|
| Merck Sharp & Dohme | Keytruda | $68 | 3 payments
|
| Janssen Biotech | Imbruvica | $65 | 1 payment
|
| Eisai | Lenvima | $62 | 3 payments
|
| Daiichi Sankyo | Enhertu | $62 | 4 payments
|
| Pfizer | Inlyta | $61 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $54 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $51 | 3 payments
|
| Lilly USA | Cyramza | $41 | 2 payments
|
| Genzyme | Jevtana | $38 | 2 payments
|
| Celgene | Abecma | $38 | 2 payments
|
| Jazz Pharmaceuticals | Zepzelca | $24 | 1 payment
|
| Ipsen Biopharmaceuticals | Somatuline Depot | $24 | 1 payment
|
| Incyte | Jakafi | $23 | 1 payment
|
| AbbVie | Venclexta | $22 | 1 payment
|
| Myovant Sciences | Orgovyx | $22 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $21 | 1 payment
|
| Sanofi-Aventis U.S. | Libtayo | $21 | 1 payment
|
| Puma Biotechnology | Nerlynx | $20 | 1 payment
|
| AMAG Pharmaceuticals | Feraheme | $19 | 1 payment
|
| MorphoSys US | Monjuvi | $17 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $15 | 1 payment
|
| Acrotech Biopharma | Marqibo | $15 | 1 payment
|
| Array Biopharma | Braftovi | $11 | 1 payment
|
| Clovis Oncology | None | $6 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1427286004
- Licence
- CA 18955California A18955: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- Po Box 255228, Sacramento, CA, 95865
- NPI first listed
- 2009-06-23
- NPI last updated
- 2026-02-23
- NPI record certified
- 2026-02-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305